Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
100 hedge funds and large institutions have $532M invested in Flexion Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 21 reducing their positions, and 19 closing their positions.
114% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 21
5% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 19
0% more funds holding
Funds holding: 100 → 100 (0)
16% less capital invested
Capital invested by funds: $632M → $532M (-$99.7M)
16% less call options, than puts
Call options by funds: $6.41M | Put options by funds: $7.64M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$12.3M |
| 2 |
State Street
Boston,
Massachusetts
|
+$11.5M |
| 3 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$11M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$7.85M |
| 5 |
NC
Nexthera Capital
New York
|
+$4.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$14.1M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$3.57M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$2.86M |
| 4 |
GAMA
Graticule Asia Macro Advisors
New York
|
-$2.07M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$2.02M |
FLXN Hedge Fund Activity: Q2 2017 in Review
100 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q2 2017, worth a combined $532M — down 16% from $632M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new FLXN positions and 19 closed out — a net gain of 1 holder — while 45 added to existing stakes and 21 trimmed.
The largest buyer was Bank of New York Mellon, adding an estimated $12.3M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $14.1M sold.
- 100 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $532M of Flexion Therapeutics, Inc. stock for Q2 2017, down 16% quarter-over-quarter.
- 20 funds opened new Flexion Therapeutics, Inc. positions in Q2 2017 and 19 closed out, a net change of +1 holder.
- The largest Flexion Therapeutics, Inc. buyer in Q2 2017 was Bank of New York Mellon, an estimated $12.3M added.
- The largest Flexion Therapeutics, Inc. seller in Q2 2017 was Driehaus Capital Management, an estimated $14.1M sold.
Based on aggregated 13F filings for Q2 2017.